Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 10:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, March 24, 2026 (GLOBE NEWSWIRE) -- As pharmaceutical innovation accelerates and clinical trial models evolve, the global clinical trial supplies market is entering a critical...
March 24, 2026 10:00 ET | Source: UpSpring

UpSpring Launches “Play with Matches,” a Podcast Exploring Bold Ideas in Architecture, Design, and the Built Environment

UpSpring launches “Play with Matches” podcast featuring architects, designers, and visionaries sparking innovation in the built environment
March 24, 2026 09:02 ET | Source: UNIGRID

UNIGRID Sodium-Ion Technology Redefines Energy Storage Bankability with 25-Year Expected Lifespan

SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- UNIGRID Inc., the ultra-safe sodium-ion battery company, today announced a breakthrough in long-cycle life cell performance, setting a new benchmark for...
March 24, 2026 08:31 ET | Source: 20/20 Biolabs Inc.

20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program

20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare
March 24, 2026 03:27 ET | Source: GENENTA SCIENCE SPA

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

MILAN, March 24, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and...
March 24, 2026 02:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
March 23, 2026 16:00 ET | Source: Levi & Korsinsky, LLP

CHOW Investor Alert: ChowChow Cloud International Holdings Limited Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Market Manipulation: Levi & Korsinsky

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ChowChow Cloud International Holdings Limited (NYSE American: CHOW) that a class action lawsuit has been...
March 23, 2026 12:00 ET | Source: Run With Duke

Candidate Rodriguez Calls for Action To Stabilize New Mexico’s ‘Too Big To Fail’ Presbyterian Healthcare Services

ALBUQUERQUE, N.M., March 23, 2026 (GLOBE NEWSWIRE) -- Republican gubernatorial candidate Duke Rodriguez today challenged New Mexico’s government leaders to take action to stabilize Presbyterian...
March 23, 2026 09:10 ET | Source: UltiSat, Inc.

UltiSat Introduces Full UMC Expeditionary Kit Portfolio, Delivering Rugged, Rapidly Deployable Connectivity Now Available

CHANTILLY, Va., March 23, 2026 (GLOBE NEWSWIRE) -- UltiSat, a global provider of advanced communications and networking solutions to government, humanitarian-aid, and critical infrastructure...
March 23, 2026 09:00 ET | Source: Property Leads

Property Leads Launches Live Transfer System to Connect Real Estate Investors with Motivated Sellers Directly

Sheridan, WY, March 23, 2026 (GLOBE NEWSWIRE) -- Property Leads announces the implementation of its live transfer system for real estate investors seeking motivated seller leads. Property Leads is...